CJC-1295 with DAC
Symbol Cd · MW 3647 Da
DAC-conjugated, long-acting GHRH analog elevating GH and IGF-1 baselines.
- Discovered
- 2006
- Half-life
- 7 days
- Approval
- Not FDA-approved
Reported effects
- Sustained GH support
- Recovery
- Lean mass
Overview
CJC-1295 with DAC is a longer-acting version of CJC-1295 designed to extend growth hormone-releasing activity in the body. DAC stands for Drug Affinity Complex, which allows the peptide to bind to albumin and remain active for a longer period. This extended half-life makes CJC-1295 with DAC a more sustained growth hormone secretagogue compared with shorter-acting options. It is commonly associated with hormone optimization, recovery support, lean body composition, and sleep quality. Its purpose is to provide longer-lasting stimulation of the body's natural growth hormone release.
How it's taken
- Typical Administration
- Injectable
- Typical Dosage
- No established approved dosage; commonly referenced range is 1–2 mg weekly
- Typical Frequency
- Once or twice weekly
Research sources
Source links included from peer-reviewed literature and trusted medical journal records for this peptide.
Interested in CJC-1295 with DAC?
Enter your email and we'll send you a curated list of vendors we trust for sourcing this peptide.
No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions.